Browse resources

Region: Global

Total results with these characteristics: 963

Page 5 of 39  
‹ prev.
2
3
4
5
6
7
8
next ›

Communication for Polio Eradication and Routine Immunization: Checklists and Easy Reference Guides

These checklists and guides cover communication and mobilization aspects of routine immunization and disease surveillance, in addition to supplemental immunization for polio eradication.

Author: World Health Organization, UNICEF, and the US Agency for International Development

Published: 2002

Communication Handbook for Polio Eradication and Routine EPI

This comprehensive reference tool is intended to help program officers learn about, design, and implement effective research-driven communication programs.

Author: World Health Organization

Published: 2001

The Communication Initiative Network

This site contains links to select programs, data, and materials, from various development organizations focused on immunization initiatives, including avian influenza and polio.

Author: The Communication Initiative Network

Comparative Evaluation of the Potential Impact of Rotavirus Versus HPV Vaccination in GAVI-Eligible Countries: A Preliminary Analysis Focused on the Relative Disease Burden

This article, published in BMC Infectious Diseases, reports on a study that aimed to provide early insight into how the comparative impact of different new vaccines could be assessed in resource-poor settings with respect to affordability, …

Author: Kim SY, Sweet S, Chang J, Goldie SJ

Published: 2011

Comparative Review of Three Cost-Effectiveness Models for Rotavirus Vaccines in National Immunization Programs: A Generic Approach Applied to Various Regions in the World

This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …

Author: Postma MJ, Jit M, Rozenbaum MH, Standaert BA, Tu HA, Hutubessy RCW

Published: 2011

The Compelling Need for Game-Changing Influenza Vaccines: An Analysis of the Influenza Vaccine Enterprise and Recommendations for the Future

This report provides a review of all aspects of influenza vaccine research and development, financing, manufacturing, efficacy, safety, regulatory issues, procurement, distribution, usage, public education, consumer acceptance, and public policy. …

Author: Center for Infectious Disease Research & Policy

Published: 2012

The Complex Journey of a Vaccine

This infographic provides a visual description of the complicated route that vaccines follow for manufacturing, formulation, packaging, and distribution, including where quality control testing is completed at each step in the process.

Author: International Federation of Pharmaceutical Manufacturers & Associations

Published: 2014

A Comprehensive Approach to Rotavirus Vaccines

This fact sheet highlights PATH's work to address rotavirus and includes general information about its efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines.

Author: PATH

Published: 2011

Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women

This World Health Organization Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions …

Author: World Health Organization

Published: 2013

Computerizing Logistics Management Information Systems: A Program Manager’s Guide

As in-country public health logistics systems become more integrated and sophisticated, many countries are looking to automate their logistics management information systems (LMIS) in order to improve the quantity, quality, and timeliness of …

Author: US Agency for International Development's DELIVER PROJECT

Published: 2012

Conducting Formative Research for HPV Vaccination Program Planning: Practical Experience from PATH

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Author: PATH

Published: 2012

Conjugate Vaccines

This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …

Author: Lockhart S

Published: 2003

Conjugate Vaccines and the Carriage of Haemophilus influenzae type b

Many junior doctors today have not had occasion to treat a child for Hib disease. The remarkable absence of cases of this disease is due to the use of conjugate vaccines. In countries with established Hib vaccination programs the incidence of …

Author: Barbour M

Published: 1996

The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II

To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Published: 2000

Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. 2nd Edition

These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …

Author: World Health Organization

Published: 1998

Control of Japanese Encephalitis--Within Our Grasp?

The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.

Author: Solomon T

Published: 2006

Coordinated Surveillance and Detection of Pneumococcal and Haemophilus influenzae type b (Hib) Disease in Developing Countries

This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …

Author: Black S, Knoll MD, eds.

Published: 2009

The Cornerstone of Public Health

This fact sheet makes the case for why vaccines are a critical, cost-effective investment for improving global health and saving children's lives.

Author: PATH

Published: 2013

Correlates of Protection: Novel Generations of Influenza Vaccines

This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …

Author: Rimmelzwaan GF, McElhaney JE

Published: 2008

The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. The authors of this article, published in Pharmacoeconomics, systematically reviewed the literature on the costs …

Author: Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC

Published: 2013

Cost Effectiveness of Rotavirus Vaccines and Other Interventions for Diarrhoeal Diseases: Meeting Report 2006

This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …

Author: World Health Organization

Published: 2006

The Cost of Immunization Programs in the Next 10 Years

This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.

Author: World Health Organization

Published: 2006

The Cost of Unsafe Injections

Unsafe injection practices are associated with substantial morbidity and mortality. Annually more than 1.3 million deaths and US$535 million in expenses are estimated to be due to unsafe injection practices. This article, published in the Bulletin …

Author: Miller MA, Pisani E

Published: 1999

Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review

This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …

Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS

Published: 2012

Cotton Rats Previously Immunized With a Chimeric RSV FG Glycoprotein Develop Enhanced Pulmonary Pathology When Infected With RSV, a Phenomenon not Encountered Following Immunization With Vaccinia-RSV Recombinants or RSV

In studies conducted in the 1960s, children previously immunized with a formalin-inactivated respiratory syncytial virus (RSV) vaccine (FI-RSV) developed a greater incidence and severity of pulmonary disease during subsequent natural RSV infection …

Author: Connors M, Collins PL, Firestone CY, et al.

Published: 1992

Page 5 of 39  
‹ prev.
2
3
4
5
6
7
8
next ›